Skip to main content
. Author manuscript; available in PMC: 2023 May 1.
Published in final edited form as: J Hepatol. 2022 Jan 21;76(5):1122–1126. doi: 10.1016/j.jhep.2021.12.040

Table 1.

Patient Characteristics by ACLF Grade

ACLF Classification by UNOS

Total (N=481) None (N=250) Grade 1 (N=75) Grade 2 (N=79) Grade 3 (N=77)
Characteristics

Male, n (%) 280 (58) 147 (59) 44 (59) 47 (60) 42 (54)

Age, median (IQR) 55 (48–61) 56 (48–61) 57 (49–62) 55 (47–61) 53 (46–60)

Non-Hispanic White, n (%) 247 (51) 143 (57) 39 (52) 32 (40) 33 (43)

Primary Listing Diagnosis, n (%)
 Alcohol 155 (32) 71 (28) 27 (36) 27 (34) 30 (39)
 NASH/Cryptogenic 103 (21) 46 (18) 21 (28) 22 (28) 14 (18)
 HBV/HCV 118 (24) 65 (26) 16 (21) 19 (24) 18 (23)
 AIH/PBC/PSC 69 (14) 44 (18) 7 (9) 7 (9) 11 (14)
 Other 36 (7) 24 (10) 4 (5) 4 (5) 4 (5)

Alcohol-Associated Hepatitis by NIAAA Criteria, n (%) 19 (4) 7 (3) 5 (7) 3 (4) 4 (5)

Primary Insurance, n (%)
 Private 163 (34) 81 (32) 31 (41) 30 (38) 21 (27)
 Medicare 157 (33) 89 (36) 24 (32) 23 (29) 21 (27)
 Medicaid 161 (33) 80 (32) 20 (27) 26 (33) 35 (45)

Hospitalized, n (%) 218 (45) 39 (16) 42 (56) 64 (81) 73 (95)

In Intensive Care Unit, n (%) 135 (28) 9 (4) 16 (21) 41 (53) 69 (90)

Diabetes, n (%) 131 (27) 53 (21) 36 (48) 22 (28) 20 (26)

MELD-Na score, median (IQR) 23 (16–34) 16 (14–20) 28 (22–33) 35 (31–39) 43 (40–45)

Organ Failures

Liver 145 (30) 9 (4) 19 (25) 48 (61) 69 (90)

Coagulation 127 (26) 2 (1) 10 (13) 45 (57) 70 (91)

Kidney 167 (35) 0 (0) 44 (59) 49 (62) 74 (96)

Brain 51 (11) 8 (3) 2 (3) 16 (20) 25 (32)

Respiratory 19 (4) 0 (0) 0 (0) 0 (0) 19 (25)

Circulatory 21 (4) 0 (0) 0 (0) 0 (0) 21 (27)